(Note: Keywords should be separated with comma)
Psychiatric disorders, encompassing conditions such as depression, anxiety, bipolar disorder, and schizophrenia, pose intricate challenges for both patients and clinicians. The complex interplay of genetic and environmental factors in mental health necessitates a personalized approach to treatment. Pharmacogenomic testing, a relatively novel advancement in psychiatric care, holds the promise of tailoring medication regimens to individuals based on their genetic makeup. As we delve into the realm of psychiatry patients' perspectives and experiences with pharmacogenomic testing, this article seeks to shed light on the transformative potential and the challenges associated with integrating genetic insights into mental health treatment.